Eight Roads | Activity | F4Eight Roads Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Investment
Participated in Fibe's $90M Series E; India's leading fintech for consumer lending and impact loans.
Fibe
Added recently
3 exits· MAR 2026 – JUN 2026Show all
Exit
Portfolio company Salowin (Japan) joined Hulic Co., Ltd.
Salowin
Exit
Portfolio company Xbit (Japan) was acquired by and joined the SmartHR Group.
Xbit
Exit
Eight Roads portfolio company J-Pharma listed on the Tokyo Stock Exchange Growth market in March 2026.
J-Pharma
Milestone
Portfolio company J-Pharma (Japan) listed on the Tokyo Stock Exchange Growth Market.
J-Pharma
Exit
Eight Roads portfolio company Shadowfax, a hyperlocal delivery pioneer, went public (IPO) in February 2026.
Shadowfax
Exit
Eight Roads portfolio company Insilico Medicine listed on the Hong Kong Stock Exchange in December 2025.
Insilico Medicine
7 investments· JUN 2024 – JUL 2025Show all
Investment
Participated in Pony.ai's $102M follow-on Series A alongside ClearVue Partners and Sequoia Capital China.
Pony.ai
Investment
Led Swan's €42M round to expand its embedded finance platform across Europe.
Swan
Investment
Co-led equity investment of ₹120 Cr in Laurus Bio, a precision fermentation and biomanufacturing CDMO platform.
Laurus Bio
Investment
Led Everstage's $30M Series B for the #1-rated sales performance management platform on G2 and Gartner.
Everstage
Investment
Participated in SPRY Therapeutics' $15M Series A; AI-powered physical therapy platform for PT clinics.
SPRY Therapeutics
Investment
Invested in Hero Software, a vertical SaaS platform serving as the operating system for tradesmen in Germany.
Hero Software
Investment
Invested in Odaseva's $54M Series C; enterprise Salesforce data security and compliance platform.
Odaseva